- « Previous
- Clinical Pharmacology
- Next »
Viread
Clinical Pharmacology
Viread
Following multiple dosing to HIV-negative subjects receiving either chronic methadone maintenance therapy or oral contraceptives, or single doses of ribavirin, steady state tenofovir pharmacokinetics were similar to those observed in previous studies, indicating lack of clinically significant drug interactions between these agents and VIREAD.
Table 4 - Drug Interactions: Changes in Pharmacokinetic Parameters
for Coadministered Drug in the Presence of VIREAD
| Coadministered Drug | Dose of Coadministered Drug (mg) |
N | % Change of Coadministered Drug Pharmacokinetic Parameters1 (90% CI) |
||
| Cmax | AUC | Cmin | |||
| Abacavir | 300 once | 8 | ↑12 ( ↓1 to ↑26) |
⇔ | NA |
| Adefovir dipivoxil | 10 once | 22 | ⇔ | ⇔ | NA |
| Atazanavir2 | 400 once daily × 14 days | 34 | ↓21 ( ↓27 to ↓14) |
↓25 ( ↓30 to ↓19) |
↓40 ( ↓48 to ↓32) |
| Atazanavir2 | Atazanavir/ Ritonavir 300/100 once daily × 42 days | 10 | ↓28 ( ↓50 to ↑5) |
↓253 ( ↓42 to ↓3) |
↓233 ( ↓46 to ↑10) |
| Efavirenz | 600 once daily × 14 days | 30 | ⇔ | ⇔ | ⇔ |
| Emtricitabine | 200 once daily × 7 days | 17 | ⇔ | ⇔ | ↑20 (↑12 to ↑29) |
| Indinavir | 800 three times daily × 7 days | 12 | ↓11 ( ↓30 to ↑12) |
⇔ | ⇔ |
| Lamivudine | 150 twice daily × 7 days | 15 | ↓24 ( ↓34 to ↓12) |
⇔ | ⇔ |
| Lopinavir Ritonavir | Lopinavir/Ritonavir 400/100 twice daily × 14 days | 24 | ⇔ | ⇔ | ⇔ |
| ⇔ | ⇔ | ⇔ | |||
| Methadone4 | 40–110 once daily × 14 days5 | 13 | ⇔ | ⇔ | ⇔ |
| Nelfinavir M8 metabolite | 1250 twice daily × 14 days | 29 | ⇔ | ⇔ | ⇔ |
| ⇔ | ⇔ | ⇔ | |||
| Oral Contraceptives6 | Ethinyl Estradiol/ Norgestimate (Ortho-Tricyclen) once daily × 7 days | 20 | ⇔ | ⇔ | ⇔ |
| Ribavirin | 600 once | 22 | ⇔ | ⇔ | NA |
| Saquinavir | Saquinavir/Ritonavir 1000/100 twice daily ×14 days | 32 | ↑22 ( ↑6 to ↑41) |
↑297 ( ↑12 to ↑48) |
↑477 (↑23 to ↑76) |
| Ritonavir | ⇔ | ⇔ | ↑23 (↑3 to ↑46) |
||
| 1.Increase = ↑; Decrease = ↓; No
Effect = ⇔ ; NA = Not Applicable 2.Reyataz Prescribing Information 3.In HIV-infected patients, addition of tenofovir DF to atazanavir 300 mg plus ritonavir 100 mg, resulted in AUC and Cmin values of atazanavir that were 2.3- and 4-fold higher than the respective values observed for atazanavir 400 mg when given alone. 4.R-(active), S- and total methadone exposures were equivalent when dosed alone or with VIREAD. 5.Individual subjects were maintained on their stable methadone dose. No pharmacodynamic alterations (opiate toxicity or withdrawal signs or symptoms) were reported. 6.Ethinyl estradiol and 17-deacetyl norgestimate (pharmacologically active metabolite) exposures were equivalent when dosed alone or with VIREAD. 7.Increases in AUC and Cmin are not expected to be clinically relevant; hence no dose adjustments are required when tenofovir DF and ritonavir-boosted saquinavir are coadministered. |
|||||
Table 5 - Drug Interactions: Pharmacokinetic Parameters for
Didanosine in the Presence of VIREAD
| Didanosine1 Dose (mg)/ Method of Administration2 |
VIREAD Method of Administration2 |
N | % Difference (90% CI) vs. Didanosine 400 mg Alone, Fasted3 | |
| Cmax | AUC | |||
| Buffered tablets | ||||
| 400 once daily4 × 7 days | Fasted 1 hour after didanosine | 14 | ↑28 (↑11 to ↑48) |
↑44 (↑31 to ↑59) |
| Enteric coated capsules | ||||
| 400 once, fasted | With food, 2 hours after didanosine | 26 | ↑48 (↑25 to ↑76) |
↑48 (↑31 to ↑67) |
| 400 once, with food | Simultaneously with didanosine | 26 | ↑64 (↑41 to ↑89) |
↑60 (↑44 to ↑79) |
| 250 once, fasted | With food, 2 hours after didanosine | 28 | ↓10 (↓22 to ↑3) |
⇔ |
| 250 once, fasted | Simultaneously with didanosine | 28 | ⇔ | ↑14 (0 to ↑31) |
| 250 once, with food | Simultaneously with didanosine | 28 | ↓29 (↓39 to ↓18) |
↓11 (↓23 to ↑2) |
| 1.See PRECAUTIONS regarding use of
didanosine with VIREAD. 2.Administration with food was with a light meal (~373 kcal, 20% fat). 3.Increase = ↑; Decrease = ↓; No Effect = ⇔ 4.Includes 4 subjects weighing < 60 kg receiving ddI 250 mg. |
||||
Description of Clinical Studies
Treatment-Naïve Patients
Study 903: VIREAD + Lamivudine +Efavirenz Compared to Stavudine + Lamivudine + Efavirenz
Generic Name: Tenofovir Disoproxil Fumarate
- « Previous
- Clinical Pharmacology
- Next »
WebMD Daily
Get breaking medical news.
HIV Test for Early Detection
There is a test that may help detect the virus sooner, so patients can start treatment much faster. See more WebMD Videos »
